Final analysis of a phase III randomized study of Topotecan (T) vs paclitaxel (P) in advanced epithelial ovarian carcinoma (OC): International Topotecan Study Group. - Gordon,A.; Carmichael,J.; Malfetano,J. (Proc Am Soc Clin Oncol, 1998)